期刊论文详细信息
Pharmaceuticals
Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
Hiroki Miyashita2  Hirotada Suzuki2  Akihide Ohkuchi1 
[1] Department of Obstetrics and Gynecology, Jichi Medical University School of Medicine, Japan;Department of Vascular Biology, Institute of Development Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan
关键词: angiogenesis inhibitor;    endothelial cell;    VASH1;    sVEGFR-1;   
DOI  :  10.3390/ph4060782
来源: mdpi
PDF
【 摘 要 】

Vasohibin-1 (VASH1) is a VEGF-inducible gene of endothelial cells (ECs) that acts as a negative feedback regulator of angiogenesis. To further characterize the function of VASH1, we transfected human VASH1 gene into the mouse EC line MS1, established stable VASH1 expressing clones, and determined gene alteration by cDNA microarray analysis. Among the various angiogenesis-related genes, vascular endothelial growth factor type 1 receptor (VEGFR-1) and its alternative spliced form, soluble VEGFR1 (sVEGFR-1), were found to be the most significantly down-regulated genes. Transient overexpression of VASH1 in human umbilical vein endothelial cells confirmed the down-regulation of VEGFR-1 and sVEGFR-1. sVEGFR-1 is a decoy receptor for VEGF and inhibits angiogenesis. Interestingly, when sVEGFR-1 was overexpressed in ECs, it inhibited the expression of VASH1 in turn. These results suggest that VASH1 and sVEGFR-1, two angiogenesis inhibitors, mutually balance their expressions in ECs.

【 授权许可】

CC BY   
© 2011 by the authors; licensee MDPI, Basel, Switzerland.

【 预 览 】
附件列表
Files Size Format View
RO202003190049189ZK.pdf 369KB PDF download
  文献评价指标  
  下载次数:1次 浏览次数:8次